常染色体显性多囊肾病患者肾功能长期变化轨迹
该研究基于CRISP队列241例ADPKD成人患者14年观察数据,按基线年龄和MRI总肾脏体积的Irazabal分型分层,重建并拟合了跨越四十余年的GFR轨迹,并用HALT-PKD数据验证。结果显示GFR下降呈非线性,轨迹形状与基线Irazabal分型强相关,PKD1突变者下降更陡,且轨迹可由单次肾脏体积测量预测。
要点
- ADPKD患者GFR下降呈非线性,多数先相对稳定后加速下降。
- 基线Irazabal分型可预测GFR轨迹形状与斜率。
- 单次肾脏体积测量可用于临床预后判断和试验设计。
核心结论
- ADPKD中GFR下降呈非线性,其成人期轨迹可由单次肾脏体积测量预测,支持肾脏体积增长与GFR下降的因果关联,并支持TKV作为临床试验替代终点。
研究设计与样本
- CRISP研究为14年观察性队列,纳入241例ADPKD成人,按基线年龄和MRI总肾脏体积的Irazabal方法分为5个亚类,用混合多项式模型拟合GFR轨迹并以HALT-PKD数据验证。
主要发现
- GFR轨迹呈非线性,多数参与者先相对稳定后加速下降。
- 轨迹形状和斜率与基线Irazabal分型强相关。
- PKD1突变者GFR下降较PKD2突变或未检出突变者更陡,主要由基因型对Irazabal分型的影响介导。
临床怎么用
- 可用单次肾脏体积测量和Irazabal分型对ADPKD患者进行临床预后判断。
- 上述模型可用于临床试验设计和患者筛选。
- TKV可作为临床试验替代终点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by cyst and kidney growth, which is hypothesized to cause loss of functioning renal mass and eventually end-stage kidney disease. However, the time course of decline in glomerular filtration rate (GFR) is poorly defined. The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease study is a 14-year observational cohort study of 241 adults with ADPKD. As an estimate of the rate of kidney growth, participants were stratified into 5 subclasses based on baseline age and magnetic resonance imaging measurements of total kidney volume (TKV) according to the method of Irazabal. GFR trajectories spanning over four decades of life were reconstructed and fitted using mixed polynomial models, which were validated using data from the HALT-PKD study. GFR trajectories were nonlinear, with a period of relative stability in most participants, followed by accelerating decline. The shape and slope of these trajectories were strongly associated with baseline Irazabal class. Patients with PKD1 mutations had a steeper GFR decline than patients with PKD2 mutations or with no detected mutation, largely mediated by the effect of genotype on Irazabal class. Thus, GFR decline in ADPKD is nonlinear, and its trajectory throughout adulthood can be predicted from a single measurement of kidney volume. These models can be used for clinical prognostication, clinical trial design, and patient selection for clinical interventions. Our findings support a causal link between growth in kidney volume and GFR decline, adding support for the use of TKV as a surrogate endpoint in clinical trials.
引用
- Yu ASL, Shen C, Landsittel DP, et al. Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease. Kidney Int. 2019. PMID: 30922668. doi:10.1016/j.kint.2018.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。